InsideTrading SEC Form 4 insider trades

Stocks

JNJ JOHNSON & JOHNSON

Healthcare · Pharmaceutical Preparations · Market cap: $687.9B

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $7.0M 2022-Q2: bought $0, sold $13.9M 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $61.2M 2023-Q1: bought $0, sold $164.2K 2023-Q2: bought $0, sold $2.0M 2023-Q3: bought $0, sold $5.9M 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $10.7M 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $930.1K 2024-Q4: bought $147.2K, sold $0 2025-Q1: bought $0, sold $3.2M 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $38.7M 2025-Q4: bought $257.7K, sold $4.2M 2026-Q1: bought $0, sold $80.5M 2026-Q2: bought $0, sold $2.4M 2026-Q3: bought $0, sold $67.8M 2026-Q4: bought $0, sold $3.7M
Bought, above the line (largest quarter $257.7K) Sold, below the line (largest quarter $80.5M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$7.0M
2022-Q2$0$13.9M
2022-Q3$0$0
2022-Q4$0$61.2M
2023-Q1$0$164.2K
2023-Q2$0$2.0M
2023-Q3$0$5.9M
2023-Q4$0$0
2024-Q1$0$10.7M
2024-Q2$0$0
2024-Q3$0$930.1K
2024-Q4$147.2K$0
2025-Q1$0$3.2M
2025-Q2$0$0
2025-Q3$0$38.7M
2025-Q4$257.7K$4.2M
2026-Q1$0$80.5M
2026-Q2$0$2.4M
2026-Q3$0$67.8M
2026-Q4$0$3.7M

Insider activity

Download CSV Up to 5,000 rows
Bought$404.9K2 buy days
Sold$303.1M47 sell days
Net insider flow-$302.7Mnet selling · 5 years
Latest trade2026-11-12Forminard Elizabeth
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-11-12 Sell Forminard Elizabeth Other C-suite 13,072 $284.39 $3.7M 1
2026-09-02 Sell Schmid Timothy Chair 33,597 $274.74 $9.2M 2
2026-08-17 Sell Taubert Jennifer L EVP / SVP 15,000 $263.36 $4.0M 1
2026-08-13 Sell Duato Joaquin CEO 123,291 $261.17 $32.2M 2
2026-08-06 Sell Forminard Elizabeth Other C-suite 15,918 $257.00 $4.1M 2
2026-08-05 Sell Duato Joaquin CEO 48,480 $258.15 $12.5M 2
2026-07-20 Sell Broadhurst Vanessa EVP / SVP 23,054 $251.27 $5.8M 1
2026-06-11 Sell Wengel Kathryn E Other C-suite 10,000 $241.15 $2.4M 1
2026-02-27 Sell Decker Robert J VP 4,075 $247.87 $1.0M 1
2026-02-20 Sell Schmid Timothy Chair 1,322 $245.66 $324.8K 1
2026-02-18 Sell Schmid Timothy Chair 22,623 $244.33 $5.5M 2
2026-02-17 Sell Wolk Joseph J CFO 89,654 $242.80 $21.8M 4
2026-02-17 Sell REED JOHN C EVP / SVP 53,931 $243.00 $13.1M 3
2026-02-17 Sell Swanson James D. Other C-suite 20,521 $242.70 $5.0M 1
2026-02-17 Sell Broadhurst Vanessa EVP / SVP 6,197 $243.39 $1.5M 1
2026-02-13 Sell Swanson James D. Other C-suite 41,559 $243.73 $10.1M 2
2026-01-26 Sell Duato Joaquin CEO 100,000 $221.23 $22.1M 2
2025-11-26 Buy MORIKIS JOHN G Director 1,250 $206.15 $257.7K 1
2025-10-17 Sell REED JOHN C EVP / SVP 21,721 $192.71 $4.2M 1
2025-09-04 Sell Taubert Jennifer L EVP / SVP 56,471 $177.81 $10.0M 1
2025-08-22 Sell Duato Joaquin CEO 125,824 $179.21 $22.5M 1
2025-08-15 Sell Wolk Joseph J CFO 16,820 $176.91 $3.0M 1
2025-07-17 Sell REED JOHN C EVP / SVP 19,137 $163.55 $3.1M 1
2025-02-25 Sell Decker Robert J VP 6,999 $165.88 $1.2M 1
2025-02-18 Sell Schmid Timothy Chair 403 $156.15 $62.9K 1
2025-02-07 Sell Wolk Joseph J CFO 13,015 $153.89 $2.0M 1
2024-12-12 Buy WEINBERGER MARK A Director 1,000 $147.22 $147.2K 1
2024-08-30 Sell Decker Robert J VP 5,635 $165.06 $930.1K 1
2024-03-13 Sell Broadhurst Vanessa EVP / SVP 8,891 $162.16 $1.4M 1
2024-02-09 Sell Taubert Jennifer L Chair 59,397 $156.27 $9.3M 1
2023-07-26 Sell Hait William Other officer 14,698 $172.00 $2.5M 1
2023-07-25 Sell Fasolo Peter Other C-suite 20,000 $170.32 $3.4M 1
2023-06-12 Sell Wengel Kathryn E Other C-suite 12,465 $160.00 $2.0M 1
2023-03-06 Sell Swanson James D. Other officer 1,062 $154.66 $164.2K 1
2022-12-13 Sell Wolk Joseph J CFO 14,781 $179.60 $2.7M 2
2022-11-30 Sell McEvoy Ashley Chair 73,323 $175.47 $12.9M 2
2022-11-22 Sell Taubert Jennifer L Chair 76,923 $176.78 $13.6M 1
2022-11-18 Sell Decker Robert J Other C-suite 16,928 $175.00 $3.0M 1
2022-11-09 Sell Wengel Kathryn E Other C-suite 16,410 $173.42 $2.8M 1
2022-11-04 Sell Mongon Thibaut Chair 35,246 $171.18 $6.0M 2
2022-10-24 Sell Fasolo Peter Other C-suite 51,758 $171.26 $8.9M 76
2022-10-24 Sell Hait William Other officer 15,000 $171.55 $2.6M 2
2022-10-19 Sell Fasolo Peter Other C-suite 53,746 $164.50 $8.8M 62
2022-06-10 Sell Wengel Kathryn E Other C-suite 40,000 $173.00 $6.9M 4
2022-05-26 Sell Decker Robert J Other C-suite 8,462 $180.00 $1.5M 1
2022-04-21 Sell Hait William Other officer 29,599 $183.58 $5.4M 7
2022-03-17 Sell Mongon Thibaut Chair 34,453 $176.25 $6.1M 35
2022-03-15 Sell Decker Robert J Other C-suite 5,000 $175.51 $877.6K 3
2021-12-07 Sell Decker Robert J Other C-suite 5,000 $163.21 $816.0K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Duato Joaquin CEO $0 $89.4M 2026-08-13
Taubert Jennifer L EVP / SVP $0 $36.9M 2026-08-17
Wolk Joseph J CFO $0 $29.4M 2026-02-17
Fasolo Peter Other C-suite $0 $21.1M 2023-07-25
REED JOHN C EVP / SVP $0 $20.4M 2026-02-17
Swanson James D. Other C-suite $0 $15.3M 2026-02-17
Schmid Timothy Chair $0 $15.1M 2026-09-02
Wengel Kathryn E Other C-suite $0 $14.2M 2026-06-11
McEvoy Ashley Chair $0 $12.9M 2022-11-30
Mongon Thibaut Chair $0 $12.1M 2022-11-04
Hait William Other officer $0 $10.5M 2023-07-26
Decker Robert J VP $0 $9.3M 2026-02-27
Broadhurst Vanessa EVP / SVP $0 $8.7M 2026-07-20
Forminard Elizabeth Other C-suite $0 $7.8M 2026-11-12
MORIKIS JOHN G Director $257.7K $0 2025-11-26
WEINBERGER MARK A Director $147.2K $0 2024-12-12

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2018-12-14 3 $502.7K 44 -1.5% (+0.5% raw)-2.1% (+7.5% raw)-3.4% (+10.8% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.